See more : Everjoy Health Group Co., Ltd. (002162.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Michlol Finance Ltd (MCLL.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Michlol Finance Ltd, a leading company in the Financial – Credit Services industry within the Financial Services sector.
- Paxman AB (publ) (PXMBF) Income Statement Analysis – Financial Results
- Innovation1 Biotech Inc. (IVBT) Income Statement Analysis – Financial Results
- TB SA Acquisition Corp (TBSAW) Income Statement Analysis – Financial Results
- Meganet Corporation (MGNT) Income Statement Analysis – Financial Results
- Euroespes, S.A. (EEP.MC) Income Statement Analysis – Financial Results
Michlol Finance Ltd (MCLL.TA)
Industry: Financial - Credit Services
Sector: Financial Services
Website: https://www.michlol-fin.co.il
About Michlol Finance Ltd
Michlol Finance Ltd, through its subsidiary, engages in financing and managing construction projects in Israel. It offers finance to entrepreneurs in the field of residential real estate through a complex of real estate; and provides credit to medium and small business corporations. The company was incorporated in 2017 and is based in Bnei Brak, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 182.52M | 68.65M | 34.59M | 32.82M | 2.45M | 306.00K |
| Cost of Revenue | 6.94M | 286.00K | 4.23M | 53.00K | 53.00K | 57.00K |
| Gross Profit | 175.59M | 68.37M | 30.36M | 32.77M | 2.40M | 249.00K |
| Gross Profit Ratio | 96.20% | 99.58% | 87.76% | 99.84% | 97.84% | 81.37% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 12.60M | 6.30M | 3.35M | 3.25M | 1.42M | 2.34M |
| Selling & Marketing | 644.00K | 1.14M | 1.07M | 199.00K | 199.00K | 0.00 |
| SG&A | 13.25M | 7.44M | 4.42M | 3.25M | 1.62M | 2.34M |
| Other Expenses | 24.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 37.57M | 30.89M | 22.13M | 9.41M | 5.23M | 2.34M |
| Cost & Expenses | 44.50M | 30.89M | 22.13M | 9.41M | 5.23M | 2.39M |
| Interest Income | 145.05M | 70.80M | 22.23M | 52.32M | 7.55M | 610.50K |
| Interest Expense | 86.66M | 29.81M | 11.63M | 14.09M | 6.79M | 0.00 |
| Depreciation & Amortization | 1.99M | 1.79M | 832.00K | 230.00K | 43.00K | 2.09M |
| EBITDA | 140.01M | 0.00 | 0.00 | 12.92M | 0.00 | 0.00 |
| EBITDA Ratio | 76.71% | 58.62% | 34.16% | 60.13% | -116.58% | -199.51% |
| Operating Income | 138.02M | 35.62M | 10.99M | 19.50M | -2.90M | -2.09M |
| Operating Income Ratio | 75.62% | 51.89% | 31.76% | 59.43% | -118.33% | -681.86% |
| Total Other Income/Expenses | -84.35M | -33.90M | -7.15M | -13.89M | -2.53M | -610.50K |
| Income Before Tax | 53.67M | 35.62M | 10.99M | 19.50M | -2.90M | -2.70M |
| Income Before Tax Ratio | 29.40% | 51.89% | 31.76% | 59.43% | -118.33% | -881.37% |
| Income Tax Expense | 12.64M | 9.18M | 5.04M | 4.23M | -1.16M | 4.50K |
| Net Income | 41.03M | 26.44M | 5.95M | 15.27M | -1.74M | -2.70M |
| Net Income Ratio | 22.48% | 38.52% | 17.19% | 46.53% | -71.17% | -882.84% |
| EPS | 0.97 | 0.65 | 0.20 | 0.37 | -0.04 | -0.07 |
| EPS Diluted | 0.97 | 0.65 | 0.20 | 0.37 | -0.04 | -0.07 |
| Weighted Avg Shares Out | 42.42M | 40.91M | 30.30M | 40.91M | 40.91M | 40.91M |
| Weighted Avg Shares Out (Dil) | 42.42M | 40.91M | 30.30M | 40.91M | 40.91M | 40.91M |
Source: https://incomestatements.info
Category: Stock Reports